Peer-reviewed veterinary case report
Autologous blood transfusion used in 25 dogs with chest or belly
By Higgs, Veronica A et al.·Published in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)·2015·Lakeshore Veterinary Specialists·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Autologous blood transfusion in dogs with thoracic or abdominal hemorrhage: 25 cases (2007-2012).
- Species:
- dog
Plain-English summary
A group of 25 dogs with severe bleeding from their chest or abdomen received autologous blood transfusions (ABT), which means their own blood was collected and given back to them. The bleeding was caused by issues like trauma, ruptured tumors, or poisoning from anticoagulant rodenticides. Most dogs tolerated the procedure well, with only minor complications like low calcium levels or changes in blood clotting times. Out of the 25 dogs, 17 survived and were able to go home after treatment, showing that ABT can be a helpful option when other blood products are not available.
People also search for: dog bleeding treatment · autologous blood transfusion dogs · dog trauma recovery · dog tumor bleeding · anticoagulant poisoning in dogs
Abstract
OBJECTIVE: To describe the use and outcome following autologous blood transfusion (ABT) in dogs. DESIGN: Retrospective study (January 2007-July 2012). SETTING: Private veterinary referral center. ANIMALS: Twenty-five dogs that underwent ABT secondary to thoracic or abdominal hemorrhage. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The hospital transaction database was searched using the keyword "autotransfusion" from January 2007 to July 2012. Data collected included signalment, body weight, etiology of hemorrhage, source and method of collection, volumes and method of ABT administration, use of anticoagulant, reported complications, and outcome. Twenty-five dogs were included for a total of 27 ABTs. Causes of hemorrhage included vascular trauma (14/25 dogs, 56%), ruptured tumor (8/25, 32%), and coagulopathy attributed to brodifacoum toxicosis (3/25, 12%). Autologous blood was collected from the abdominal (19/25, 76%), thoracic (5/25, 20%), or abdominal and thoracic cavities (1/25, 4%). Anticoagulant was added to the ABT blood in 13 of 25 (52%) cases. A median ABT volume of 29.3 mL/kg (range 2.9-406.9 mL/kg) was infused through either a 210 μm blood administration filter (21/27, 78%) or an 18 μm hemonate filter (6/27, 22%). Reported complications that may have been associated with ABT included hypocalcemia (4/17, 24%), hemolyzed serum (5/19, 26%), and prolonged coagulation times (4/5, 80%). These complications were considered of minimal clinical significance. Additional blood products were administered in 17 of 25 (68%) dogs. Seventeen (68%) dogs survived to discharge. Cause of death in the remaining cases was euthanasia or cardiac arrest secondary to uncontrollable hemorrhage. CONCLUSIONS: ABT is an adjunct to volume replacement in dogs with thoracic or abdominal hemorrhage secondary to vascular trauma, ruptured tumor, or anticoagulant rodenticide toxicosis. ABT may be used as bridge to definitive hemorrhage control, particularly when other blood products are not available or affordable. Complications may include hypocalcemia, prolonged coagulation times, and hemolysis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26193912/